 |
Deoxycytidine - Administration & dosage
Research News and Information
Sunday, March 21, 2010
30 Oct 2009 
This study aim was to determine the efficacy and safety of the combination of Gemcitabine 1000 mg/m(2) day 1 & 8 and Irinotecan 100 mg/m(2) day 1 & 8 with escalating dose of thalidomide in chemonaive patients with advanced non-small cell lung ... Read more...
29 Sep 2009 OBJECTIVE: The objective of our study was to retrospectively determine the effectiveness of hepatic transarterial chemotherapy using two therapeutic protocols-mitomycin C alone and combined mitomycin C and gemcitabine-on local tumor control and ... Read more...
Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts.
29 Sep 2009 PURPOSE: To evaluate the feasibility of using neural networks for predicting treatment response by using longitudinal measurements of apparent diffusion coefficient (ADC) obtained from diffusion-weighted magnetic resonance imaging (DWMRI). METHODS ... Read more...
Latest indexed articles for 'Deoxycytidine - Administration & dosage'
These are the very latest articles for this heading:
- Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer. 30 Oct 2009
- Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. 29 Sep 2009
- Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts. 29 Sep 2009
- Treatment of disseminated paraganglioma with gemcitabine and docetaxel. 29 Sep 2009
- Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment. 20 Sep 2009
- Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. 19 Sep 2009
- Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group. 6 Sep 2009
- Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group. 2 Sep 2009
- Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer. Sep 2009
- Brief report of biweekly pemetrexed and gemcitabine in elderly patients with non-small cell lung cancer. 30 Aug 2009
- Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial. 30 Aug 2009
- Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. 30 Aug 2009
- [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide] 30 Aug 2009
- CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. 30 Aug 2009
- The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. 30 Aug 2009
- Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. 29 Aug 2009
- Cancer and chemotherapy.
22 Aug 2009 - Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). 16 Aug 2009
- Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. 16 Aug 2009
- A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals. 13 Aug 2009
See a longer list of these articles.
Technical information about 'Deoxycytidine'
Chemical name: Cytidine, 2'-deoxy-
Registry Number: 951-77-9
Descriptor UI: D003841
Alternative terms: Deoxycytidine; CDR; Cytosine Deoxyribonucleoside; Deoxyribonucleoside, Cytosine; Cytosine Deoxyriboside; Deoxyriboside, Cytosine;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D03.383.742.680.245.500; D13.570.230.329; D13.570.685.245.500;
History Note: 75(73)